It was reported [34–36] that increased levels of HIF-1 or HIF-2 were correlated with adverse prognosis in breast, cervical, endometrial, colorectal, NSCLC, ovarian, rectal, pancreatic and prostate cancers. The gene discussed is HIF1A; the disease is Familial prostate cancer.